Personal information

Other IDs

Scopus Author ID: 55314905400

Countries

Brazil

Activities

Collapse all

Employment (3)

Federal University of Ceará: Fortaleza, Ceará, BR

2024-12-03 to present | Professor (Department of Pharmacy)
Employment
Source: Self-asserted source
Raquel Petrilli

Universidade da Integração Internacional da Lusofonia Afro-Brasileira: Redencao, CE, BR

2020-01-15 to 2024-12-02 | Professor (ICS)
Employment
Source: Self-asserted source
Raquel Petrilli

Federal University of Ceara: Fortaleza, BR

2019-04-10 to 2020-01 | Visiting Professor
Employment
Source: Self-asserted source
Raquel Petrilli

Education and qualifications (4)

Universidade de São Paulo Faculdade de Ciências Farmacêuticas de Ribeirão Preto: Ribeirao Preto, SP, BR

2017-06 to 2019-04 | Post-doctorate in Pharmaceutical Sciences
Education
Source: Self-asserted source
Raquel Petrilli

Universidade de São Paulo Faculdade de Ciências Farmacêuticas de Ribeirão Preto: Ribeirao Preto, SP, BR

2013-03 to 2017-01 | Ph.D. in Pharmaceutical Sciences
Education
Source: Self-asserted source
Raquel Petrilli

Universidade de São Paulo Faculdade de Ciências Farmacêuticas de Ribeirão Preto: Ribeirao Preto, SP, BR

2011 to 2013 | Master´s in Pharmaceutical Sciences
Education
Source: Self-asserted source
Raquel Petrilli

Universidade de São Paulo Faculdade de Ciências Farmacêuticas de Ribeirão Preto: Ribeirao Preto, SP, BR

2006 to 2010 | Bachelor degree: Pharmacy-Biochemistry
Education
Source: Self-asserted source
Raquel Petrilli

Funding (2)

Imunolipossoma anti-EGFR como sistema teranóstico para liberação direcionada de 5-fluorouracil e R-ficoeritrina no câncer colorretal

2022-08 to 2024-08 | Grant
Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico (Redenção, BR)
Source: Self-asserted source
Raquel Petrilli

Anti-EGFR Liposomes for Topical Treatment of Squamous Cell Carcinoma Using Photodynamic Therapy and Physical Methods

2019 to 2022 | Grant
Conselho Nacional de Desenvolvimento Científico e Tecnológico (Brazil, BR)
Source: Self-asserted source
Raquel Petrilli

Works (34)

Chloro-aluminum phthalocyanine encapsulation into liquid crystalline nanodispersions enhance skin penetration and phototoxicity in skin cancer cells

Journal of Drug Delivery Science and Technology
2024-11 | Journal article
DOI: 10.1016/j.jddst.2024.106198
Contributors: Márcia Hermínia Pinheiro Borges; Alice Vitoria Frota Reis; Thais da Silva Moreira; Marcia Carvalho de Abreu Fantini; Cristiano Luís Pinto de Oliveira; Roberto Nicolete; Josimar O. Eloy; Raquel Petrilli
Source: check_circle
Crossref

Development of Liposomes Loaded with Chloroaluminum Phthalocyanine for Application of Photodynamic Therapy in Breast Cancer

Journal of Pharmaceutical Sciences
2024-08 | Journal article
DOI: 10.1016/j.xphs.2024.04.022
Contributors: Karina Alexandre Barros Nogueira; Alice Vitoria Frota Reis; Yara Santiago de Oliveira; João Isaac Silva Miranda; Antonio Claudio Tedesco; Alejandro Pedro Ayala; Claudia Pessoa; Josimar O. Eloy; Ivanildo José da Silva Júnior; Raquel Petrilli
Source: check_circle
Crossref

Simvastatin-loaded alginate bilayer membranes for wound dressing applications

Journal of Drug Delivery Science and Technology
2023-09 | Journal article
DOI: 10.1016/j.jddst.2023.104701
Contributors: Rubens T. Monteiro; Thamyres F. Da Silva; RaimundoN.F. Moreira Filho; Niédja F. Vasconcelos; KarinaA.B. Nogueira; Raquel Petrilli; Fabia K. Andrade; Rodrigo S. Vieira
Source: check_circle
Crossref

DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells

Pharmaceutics
2023-03 | Journal article | Author
DOI: 10.3390/pharmaceutics15030915
Contributors: Thais da Silva Moreira; Alan Denis Olivindo Silva; Bianca Rodrigues Farias Vasconcelos; Elias da Silva Santos; Ana Carolina Cruz de Sousa; João Vito Barroso de Freitas; Yara Santiago de Oliveira; Laura Vidal; Fábio de Oliveira Silva Ribeiro; Alyne Rodrigues de Araújo et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Immunoconjugates for Cancer Targeting: A Review of Antibody-Drug Conjugates and Antibody-Functionalized Nanoparticles

Current Medicinal Chemistry
2021-04 | Journal article
DOI: 10.2174/0929867327666200525161359
Contributors: Raquel Petrilli; Daniel Pascoalino Pinheiro; Fátima de Cássia Evangelista de Oliveira; Gabriela Fávero Galvão; Lana Grasiela Alves Marques; Renata Fonseca Vianna Lopez; Claudia Pessoa; Josimar O. Eloy
Source: check_circle
Crossref

EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles

International Journal of Pharmaceutics
2021-01 | Journal article
DOI: 10.1016/j.ijpharm.2020.120082
Contributors: Elias da Silva Santos; Karina Alexandre Barros Nogueira; Luiziana Cavalcante Costa Fernandes; Jéssica Roberta Pereira Martins; Alice Vitoria Frota Reis; José de Brito Vieira Neto; Ivanildo José da Silva Júnior; Claudia Pessoa; Raquel Petrilli; Josimar O. Eloy
Source: check_circle
Crossref

A Critical Review of Properties and Analytical/Bioanalytical Methods for Characterization of Cetuximab

Critical Reviews in Analytical Chemistry
2020 | Journal article
DOI: 10.1080/10408347.2019.1581984
EID:

2-s2.0-85062979559
Contributors: Hanck-Silva, G.; Fatori Trevizan, L.N.; Petrilli, R.; de Lima, F.T.; Eloy, J.O.; Chorilli, M.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells

Colloids and Surfaces B: Biointerfaces
2020 | Journal article
DOI: 10.1016/j.colsurfb.2020.111185
EID:

2-s2.0-85086642219

Part of ISBN:

18734367 09277765
Contributors: Eloy, J.O.; Ruiz, A.; de Lima, F.T.; Petrilli, R.; Raspantini, G.; Nogueira, K.A.B.; Santos, E.; de Oliveira, C.S.; Borges, J.C.; Marchetti, J.M. et al.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Liposome-based nanocarrier loaded with a new quinoxaline derivative for the treatment of cutaneous leishmaniasis

Materials Science and Engineering C
2020 | Journal article
DOI: 10.1016/j.msec.2020.110720
EID:

2-s2.0-85079332632

Part of ISBN:

18730191 09284931
Contributors: de Oliveira, J.K.; Ueda-Nakamura, T.; Corrêa, A.G.; Petrilli, R.; Lopez, R.F.V.; Nakamura, C.V.; Auzely-Velty, R.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Nitrosation of BODIPY dyes and their applications in the development of thiol sensors

Dyes and Pigments
2020 | Journal article
DOI: 10.1016/j.dyepig.2019.107885
EID:

2-s2.0-85072300439
Contributors: Gil de Melo, S.M.; de Rezende, L.C.D.; Petrilli, R.; Vianna Lopez, R.F.; Goulart, M.O.F.; da Silva Emery, F.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Production and characterization of alginate bilayer membranes for releasing simvastatin to treat wounds

Biointerphases
2020 | Journal article
DOI: 10.1116/6.0000167
EID:

2-s2.0-85088154942

Part of ISBN:

15594106 19348630
Contributors: Monteiro, R.T.; Andrade, F.K.; Vasconcelos, N.F.; Nogueira, K.A.B.; Petrilli, R.; Vieira, R.S.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

The prominence of the dosage form design to treat ocular diseases

International Journal of Pharmaceutics
2020-08 | Journal article
DOI: 10.1016/j.ijpharm.2020.119577
Contributors: Patrícia Mazureki Campos; Raquel Petrilli; Renata F.V. Lopez
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries

European Journal of Pharmaceutics and Biopharmaceutics
2019 | Journal article
DOI: 10.1016/j.ejpb.2019.04.014
EID:

2-s2.0-85064664877
Contributors: Cruz-Cazarim, E.L.C.; Cazarim, M.S.; Ogunjimi, A.T.; Petrilli, R.; Rocha, E.M.; Lopez, R.F.V.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models

European Journal of Pharmaceutical Sciences
2018 | Journal article
DOI: 10.1016/j.ejps.2017.09.034
EID:

2-s2.0-85030307984
Contributors: Praça, F.S.G.; Medina, W.S.G.; Eloy, J.O.; Petrilli, R.; Campos, P.M.; Ascenso, A.; Bentley, M.V.L.B.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Physical methods for topical skin drug delivery: Concepts and applications

Brazilian Journal of Pharmaceutical Sciences
2018 | Journal article
DOI: 10.1590/s2175-97902018000001008
EID:

2-s2.0-85056563728
Contributors: Petrilli, R.; Lopez, R.F.V.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Preparation of immunoliposomes by direct coupling of antibodies based on a thioether bond

Methods in Molecular Biology
2018 | Book
DOI: 10.1007/978-1-4939-7312-5_19
EID:

2-s2.0-85029726294
Contributors: Petrilli, R.; Eloy, J.O.; Lee, R.J.; Lopez, R.F.V.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Quantification of 5-FU in skin samples for the development of new delivery systems for topical cancer treatment

Pharmazie
2018 | Journal article
DOI: 10.1691/ph.2018.7138
EID:

2-s2.0-85044123896
Contributors: Petrilli, R.; Eloy, J.O.; Paschoal, J.A.R.; Lopez, R.F.V.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection

Journal of Controlled Release
2018 | Journal article
DOI: 10.1016/j.jconrel.2018.05.038
EID:

2-s2.0-85048633855
Contributors: Petrilli, R.; Eloy, J.O.; Saggioro, F.P.; Chesca, D.L.; de Souza, M.C.; Dias, M.V.S.; daSilva, L.L.P.; Lee, R.J.; Lopez, R.F.V.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Targeted Liposomes for siRNA Delivery to Cancer

Current pharmaceutical design
2018 | Journal article
DOI: 10.2174/1381612824666180807121935
EID:

2-s2.0-85055637869
Contributors: Eloy, J.O.; Petrilli, R.; Raspantini, G.L.; Lee, R.J.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy

European Journal of Pharmaceutics and Biopharmaceutics
2017 | Journal article
DOI: 10.1016/j.ejpb.2017.02.020
EID:

2-s2.0-85014463350
Contributors: Eloy, J.O.; Petrilli, R.; Chesca, D.L.; Saggioro, F.P.; Lee, R.J.; Marchetti, J.M.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells

Anti-Cancer Agents in Medicinal Chemistry
2017 | Journal article
DOI: 10.2174/1871520616666160526110913
EID:

2-s2.0-85011094181
Contributors: Petrilli, R.; Eloy, J.O.; Lopez, R.F.V.; Lee, R.J.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Immunoliposomes: A review on functionalization strategies and targets for drug delivery

Colloids and Surfaces B: Biointerfaces
2017 | Journal article
DOI: 10.1016/j.colsurfb.2017.07.085
EID:

2-s2.0-85027856689
Contributors: Eloy, J.O.; Petrilli, R.; Trevizan, L.N.F.; Chorilli, M.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Liquid-crystalline nanodispersions containing monoolein for photodynamic therapy of skin diseases: A mini-review

Current Nanoscience
2017 | Journal article
DOI: 10.2174/1573413713666170529115831
EID:

2-s2.0-85029629963
Contributors: Praça, F.G.; Petrilli, R.; Eloy, J.O.; Lee, R.J.; Badra Bentley, M.V.L.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Rapamycin-loaded immunoliposomes functionalized with trastuzumab: A strategy to enhance cytotoxicity to HER2-positive breast cancer cells

Anti-Cancer Agents in Medicinal Chemistry
2017 | Journal article
DOI: 10.2174/1871520616666160526103432
EID:

2-s2.0-85014462357
Contributors: Eloy, J.O.; Petrilli, R.; Brueggemeier, R.W.; Marchetti, J.M.; Lee, R.J.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Topical photodynamic therapy for skin diseases: Current status of preclinical and clinical research, nanocarriers and physical methods for photosensitizer delivery

Carrier-Mediated Dermal Delivery: Applications in the Prevention and Treatment of Skin Disorders
2017 | Book
Part of DOI: 10.4324/9781315364476
EID:

2-s2.0-85054768723
Contributors: Praça, F.S.G.; Campos, P.M.; Eloy, J.O.; Petrilli, R.; Bentley, M.V.L.B.; Medina, W.S.G.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy

Colloids and Surfaces B: Biointerfaces
2016 | Journal article
DOI: 10.1016/j.colsurfb.2016.01.032
EID:

2-s2.0-84961345883
Contributors: Eloy, J.O.; Petrilli, R.; Topan, J.F.; Antonio, H.M.R.; Barcellos, J.P.A.; Chesca, D.L.; Serafini, L.N.; Tiezzi, D.G.; Lee, R.J.; Marchetti, J.M.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Lipid nanoparticles as non-viral vectors for siRNA delivery: Concepts and applications

Nanobiomaterials in Drug Delivery: Applications of Nanobiomaterials
2016 | Book
Part of DOI: 10.1016/B978-0-323-42866-8.00003-4
EID:

2-s2.0-84980329372
Contributors: Petrilli, R.; Eloy, J.O.; de Souza, M.C.; Abriata Barcellos, J.P.; Marchetti, J.M.; Yung, B.; Lee, R.J.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Liquid crystalline nanodispersions functionalized with cell-penetrating peptides for topical delivery of short-interfering RNAs: A proposal for silencing a pro-inflammatory cytokine in cutaneous diseases

Journal of Biomedical Nanotechnology
2016 | Journal article
DOI: 10.1166/jbn.2016.2211
EID:

2-s2.0-84962513575
Contributors: Petrilli, R.; Eloy, J.O.; Praça, F.S.G.; Del Ciampo, J.O.; Fantini, M.A.C.; Fonseca, M.J.V.; Bentley, M.V.L.B.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Stimuli-responsive nanoparticles for siRNA delivery

Current Pharmaceutical Design
2015 | Journal article
DOI: 10.2174/1381612821666150901095349
EID:

2-s2.0-84945897995
Contributors: Eloy, J.O.; Petrilli, R.; Lopez, R.F.V.; Lee, R.J.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery

Colloids and Surfaces B: Biointerfaces
2014 | Journal article
DOI: 10.1016/j.colsurfb.2014.09.029
EID:

2-s2.0-84915782365
Contributors: Eloy, J.O.; Claro de Souza, M.; Petrilli, R.; Barcellos, J.P.A.; Lee, R.J.; Marchetti, J.M.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Targeted lipid nanoparticles for antisense oligonucleotide delivery

Current Pharmaceutical Biotechnology
2014 | Journal article
DOI: 10.2174/1389201015666141020155834
EID:

2-s2.0-84920571100
Contributors: Petrilli, R.; Eloy, J.O.; Marchetti, J.M.; Lopez, R.F.; Lee, R.J.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Delivery systems and local administration routes for therapeutic siRNA

Pharmaceutical Research
2013 | Journal article
DOI: 10.1007/s11095-013-0971-1
EID:

2-s2.0-84876497020
Contributors: Vicentini, F.T.M.D.C.; Borgheti-Cardoso, L.N.; Depieri, L.V.; De MacEdo Mano, D.; Abelha, T.F.; Petrilli, R.; Bentley, M.V.L.B.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Nanoparticles of lyotropic liquid crystals: A novel strategy for the topical delivery of a chlorin derivative for photodynamic therapy of skin cancer

Current Nanoscience
2013 | Journal article
DOI: 10.2174/1573413711309040003
EID:

2-s2.0-84882760668
Contributors: Petrilli, R.; Praça, F.S.G.; Carollo, A.R.H.; Medina, W.S.G.; De Oliveira, K.T.; Fantini, M.C.A.; Neves, M.G.P.M.S.; Cavaleiro, J.A.S.; Serra, O.A.; Iamamoto, Y. et al.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Liquid crystal nanodispersions enable the cutaneous delivery of photosensitizer for topical PDT: Fluorescence microscopy study of skin penetration

Current Nanoscience
2012 | Journal article
DOI: 10.2174/157341312801784203
EID:

2-s2.0-84863933226
Contributors: Praça, F.S.G.; Medina, W.S.G.; Petrilli, R.; Bentley, M.V.L.B.
Source: Self-asserted source
Raquel Petrilli via Scopus - Elsevier

Peer review (1 review for 1 publication/grant)

Review activity for Brazilian Journal of Chemical Engineering. (1)
How many people are using ORCID?